电邮这篇文章 Extremely high concentration of mexotrexate in blood serum leading to development of acute renal failure in a patient with acute lymphoblastic leukemia after high-dose consolidation
- 作者: Pimenova M.A.1, Sokolov A.N.1, Biryukova L.S.1, Ustinova E.N.1, Shaforostova I.I.1, Donskova I.A.1, Bogdanov R.F.1, Parovichnikova E.N.1, Savchenko V.G.1, Pimenova MA2, Sokolov AN2, Biryukova LS2, Ustinova EN2, Shaforostova II2, Donskova IA2, Bogdanov RF2, Parovichnikova EN2, Savchenko VG2
-
隶属关系:
- Hematological Research Center, Moscow
- 期: 卷 83, 编号 7 (2011)
- 页面: 58-61
- 栏目: Editorial
- ##submission.dateSubmitted##: 10.04.2020
- ##submission.datePublished##: 15.07.2011
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30890
- ID: 30890
如何引用文章
全文:
详细
作者简介
Mariya Pimenova
Email: maria_pimenova@mail.ru
Andrey Sokolov
Email: cat@blood.ru
Lyudmila Biryukova
Email: birjukova@blood.ru
Elena Ustinova
Inna Shaforostova
Email: shiil@yandex.ru
Irina Donskova
Email: irina.donskova99@mail.ru
Rashit Bogdanov
Email: rashit85@mail.ru
Elena Parovichnikova
Email: elenap@blood.ru
Valeriy Savchenko
Email: svg@blood.ru
M Pimenova
Hematological Research Center, MoscowHematological Research Center, Moscow
A Sokolov
Hematological Research Center, MoscowHematological Research Center, Moscow
L Biryukova
Hematological Research Center, MoscowHematological Research Center, Moscow
E Ustinova
Hematological Research Center, MoscowHematological Research Center, Moscow
I Shaforostova
Hematological Research Center, MoscowHematological Research Center, Moscow
I Donskova
Hematological Research Center, MoscowHematological Research Center, Moscow
R Bogdanov
Hematological Research Center, MoscowHematological Research Center, Moscow
E Parovichnikova
Hematological Research Center, MoscowHematological Research Center, Moscow
V Savchenko
Hematological Research Center, MoscowHematological Research Center, Moscow
参考
- LaCasce Ann S. MD Therapeutic use of high-dose methotrexate. http:// www.uptodate.com/patients/.
- Warrier A. R., Rejiv R., Biswajit D. et al. High-dose methotrexate in the treatment of acute lymphoblastic leukemia: Toxicity profile and comparison of tolerability betwen two dosage schedules. J. Clin. Oncol. 2010; 28 (suppl 15): abstr. 9573.
- Widemann B. C., Adamson P. S. et al. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006; 1(6): 694-703.
- Pitman S. W., Frei E. 3rd. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat. Rep. 1977; 61 (4): 695-701.
- Flombaum C. D., Meyers P. A. et al. High-dose leucovorin as sole therapy for Methotrexate toxicity. J. Clin. Oncol. 1999; 17(5): 1589.
- Wilmanns W., Sauer H., Schalhorn A. et al. Biochemical control of high-dose methotrexate/Leucovorin rescue therapy. Recent Results Cancer Res. 1980; 74: 42-49.
- Schmiegelow K. Advances in individual prediction of methotrexate toxicity: a review. Br. J. Haematol. 2009; 146(5): 489-503.
- Relling M. V., Fairclough D., Ayers D. et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J. Clin. Oncol. 1994; 12: 1667-1672.
- Schwartz S., Borner K., Müller K. et al. Glucarpidase (Carboxypeptidase G2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy. Oncologist 2007; 12(11): 1299-1308.
- Liu J. X., Chen J. P. Tan W., Lin D. X. Association between mothfr gene polymorphisms and toxicity of HDMTX chemotherapy in acute lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16(3): 488-492.
- Chiusolo P., Reddiconto G., Casorelli I. et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann. Oncol. 2002; 13 (12): 1915-1918.
- Паровичникова Е. Н., Давидян Ю. Р., Исаев В. Г. Итоги лечения острых лимфобластных лейкозов взрослых по протоколу ОЛЛ-2005 как основа для новых исследований. Тер. арх. 2009; 7: 6-15.
- Fisher M. C., Cronstein B. N. Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J. Rheumatol. 2009; 36(3): 539-557.
补充文件
